Systems profiling reveals recurrently dysregulated cytokine signaling responses in ER+ breast cancer patients' blood
B. Orcutt-Jahns, J. R. Lima Junior, R. C. Rockne, A. Matache, S. Branciamore, E. Hung, A. S. Rodin, P. P. Lee, A. S. Meyer
The paper profiles cytokine signaling responses in breast cancer patients and finds coordinated dysregulation across pathways and cell types, suggesting immune cell reprogramming and immunosuppression.
bioRxiv · Oct 31, 2023Cancer Biology